Basics Keros Therapeutics, Inc. IPO Date: April 8, 2020 Sector: Healthcare Industry: Biotech Market Cap: $660.81M Activated in VL: True Average Daily Range Avg Daily Range: $1.14 | 2.66% Avg Daily Range (30 D): $0.40 | 2.30% Avg Daily Range (90 D): $0.32 | 2.01% Institutional Daily Volume Avg Daily Volume: .29M Avg Daily Volume (30 D): .91M Avg Daily Volume (90 D): .63M Trade Size Avg Trade Size (Sh.): 60 Avg Trade Size (Sh.) (30 D): 67 Avg Trade Size (Sh.) (90 D): 69 Institutional Trades Total Inst.Trades: 2,027 Avg Inst. Trade: $1.9M Avg Inst. Trade (30 D): $3.48M Avg Inst. Trade (90 D): $2.07M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.94M Avg Closing Trade (30 D): $3.12M Avg Closing Trade (90 D): $1.82M Avg Closing Volume: 58.56K     News Nov 20, 2025 @ 9:01 PM Keros Therapeutics Announces Final Results of Tend... Source: Globe Newswire Nov 19, 2025 @ 11:00 AM Keros Therapeutics Announces Preliminary Results o... Source: Keros Therapeutics, Inc. Sep 23, 2025 @ 5:00 PM TGF-β Inhibitors Clinical Trial Pipeline Accele... Source: Delveinsight May 27, 2025 @ 5:45 PM Leading Independent Proxy Advisory Firm Glass Lewi... Source: Keros Therapeutics, Inc. May 12, 2025 @ 5:00 PM Blood Cancer Treatment Market Sees Accelerated Gro... Source: Delveinsight Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.18 $-.76 $3.66 Diluted EPS $-.18 $-.76 $3.62 Revenue $ 14.12M $ 18.17M $ 211.19M Gross Profit $ $ $ Net Income / Loss $ -7.28M $ -30.7M $ 148.45M Operating Income / Loss $ -15.38M $ -39.82M $ 152.04M Cost of Revenue $ $ $ Net Cash Flow $ 3.26M $ -30.33M $ 160.61M PE Ratio